Acadia Pharmaceuticals (ACAD) Amortizatization of Intangibles (2011 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly Amortizatization of Intangibles of $453000.0 for Q1 2026, down 78.59% year-over-year from $2.1 million in Q1 2025, and down 32.39% quarter-over-quarter from $670000.0 in Q4 2025.
Acadia Pharmaceuticals (ACAD) Amortizatization of Intangibles (2011 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Amortizatization of Intangibles history runs 16 years deep, the most recent figure standing at $453000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 78.59% year-over-year to $453000.0; the TTM figure through Mar 2026 stood at $3.8 million (down 60.96% YoY), while the FY2025 annual figure was $5.4 million, down 41.7% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $453000.0, down from $670000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.8 million in Q4 2024, with the low at -$447000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $1.8 million (2023), against an average of $1.5 million.
- The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles soared 1591.0% in 2023, then plunged 78.59% in 2026.
- Acadia Pharmaceuticals' Amortizatization of Intangibles stood at $2.1 million in 2022, then slipped by 15.04% to $1.8 million in 2023, then jumped by 58.35% to $2.8 million in 2024, then slumped by 76.22% to $670000.0 in 2025, then tumbled by 32.39% to $453000.0 in 2026.
- Business Quant data shows ACAD's Amortizatization of Intangibles at $453000.0 in Q1 2026, $670000.0 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.33 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 678,000.00 |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn | 50,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50,000.00 |
| Jun 30, 2026 | 50,000.00 |
| Mar 31, 2026 | 453,000.00 |
| Mar 31, 2026 | 453,000.00 |
| Dec 31, 2025 | 670,000.00 |
| Dec 31, 2025 | 670,000.00 |
| Sep 30, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 2.75 Mn |
| Sep 30, 2024 | 2.75 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 1.79 Mn |
| Mar 31, 2024 | 1.79 Mn |